Home News ‘Every nook and corner’ of Karnataka may get Covid-19 vaccine by early...

‘Every nook and corner’ of Karnataka may get Covid-19 vaccine by early 2021

Karnataka Health and Medical Education Minister K Sudhakar met with pharma giant AstraZeneca after the latter successfully conducted the first phase of vaccine trials

Karnataka may get COVID-19 vaccine by early 2021 and once it’s available the state government will ensure it reaches “every nook and corner of the state”, said Karnataka Health and Medical Education Minister K Sudhakar on October 27, 2020. He made this statement right after he met with AstraZeneca, a pharmaceutical company that is conducting coronavirus vaccine trials.

AstraZeneca, in collaboration with Pune’s Serum Institute and Oxford University, has undertaken vaccine trials. They successfully conducted the first phase of the trial for 56 days and are set to conduct the second and third levels of trial on 1,600 people. The distribution of the vaccine within the state was also discussed in this meeting.

The minister said if the second- and third-level trials are successful, they will start issuing the vaccine in the state after the central government’s approval. AstraZeneca’s project plans to supply vaccines for 100 crore people, added the minister.

During the first level of trials, the antibodies were produced in 28 days, and it was conducted on uninfected people first. However, the second and third levels include vaccinating the recovered COVID-19 patients.
Since the vaccine is under trial, its price has not been decided yet. Technical committees will be formed in collaboration with the Ministry of Health and Family Welfare to distribute the vaccine.

Gagandeep Singh, managing director of AstraZeneca, and Dr Sudharshan, chairman of the Technical Advisory Committee, were also present at the meeting.

AstraZeneca India, a subsidiary of Astra Zeneca Plc, UK, is headquartered in Bengaluru, Karnataka. It covers manufacturing, sales and marketing operations of the company in India. The company majorly works in the area of cancer, cardiovascular, gastrointestinal and respiratory illnesses, inflammation and infections. It is a British and Swedish biopharmaceutical company that produces and markets medicines used by millions of people around the world making it one of the top 10 biopharmaceutical companies in the world.

Sampurna Maity
| Writer | Dancer | Travel Enthusiast | Foodie |


Please enter your comment!
Please enter your name here

Most Popular

MeitY issues ban of 43 new mobile apps under section 69A of IT Act

Earlier, the Government of India had blocked access to 59 mobile apps and on 2nd September 2020, 118 more apps were banned under the...

Micromax announces second sale of In Note 1 from December 1

Indian smartphone maker Micromax has now announced the second sale of its newly launched smartphone In Note 1 from December 1 (12 noon). Micromax...

Moto G 5G and Moto G9 Power to launch in India soon

Moto G 5G and Moto G9 Power that was announced earlier this month in Europe, may soon get launched in India.  A tipster Mukul...

Intel shows how AMD CPUs have a 10-second performance delay

In what seems to be an attempt at covering its dismal quarterly performances, Intel, in a recent embargoed presentation demonstrated that AMD’s flagship Zen...

Recent Comments